Journalartikel

In vitro selection of exonic splicing enhancer sequences: identification of novel CD44 enhancers


AutorenlisteWoerfel, G; Bindereif, A

Jahr der Veröffentlichung2001

Seiten3204-3211

ZeitschriftNucleic Acids Research

Bandnummer29

Heftnummer15

ISSN0305-1048

eISSN1362-4962

Open Access StatusGreen

DOI Linkhttps://doi.org/10.1093/nar/29.15.3204

VerlagOxford University Press


Abstract
We have developed an in vitro selection procedure that allows the identification and isolation of functional splicing enhancer sequences from any cDNA. It is based on the enhancement of general splicing activity of a pre-mRNA reporter derived from the Drosophila dsx gene. Short DNase I fragments are cloned into a cassette in the second exon of the reporter construct, replacing the natural dsx enhancer. After splicing and reverse transcription-PCR, fragments are recovered from the mRNA product. Applying this selection to the CD44 gene, which undergoes extensive alternative splicing processes, we have identified several novel exonic enhancers. Two of them, which reside in CD44 variable exon 6, were further characterized by mutational analysis and confirmed to function within their natural CD44 context.



Zitierstile

Harvard-ZitierstilWoerfel, G. and Bindereif, A. (2001) In vitro selection of exonic splicing enhancer sequences: identification of novel CD44 enhancers, Nucleic Acids Research, 29(15), pp. 3204-3211. https://doi.org/10.1093/nar/29.15.3204

APA-ZitierstilWoerfel, G., & Bindereif, A. (2001). In vitro selection of exonic splicing enhancer sequences: identification of novel CD44 enhancers. Nucleic Acids Research. 29(15), 3204-3211. https://doi.org/10.1093/nar/29.15.3204



Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-10-06 um 09:25